Have you missed CILcare’s presentation on chronic inflammatory diseases and hearing loss at Inner Ear Disorders Therapeutics Summit 2022?
Mathieu SCHUE, PhD, CILcare’s Project Director in Drug Development and Translational Research, held an official presentation on June 21st, 2022 at the Inner Ear Disorders Therapeutics Summit as part of the “Seeking Improved Outcomes for Patients with Inner Ear Diseases” session. Dr Schue presented in Boston to industry and academic experts from the hearing field, as well as innovative biopharmaceutical actors. During this talk, Dr Schue went into details about:
- The increased risk for sensorineural hearing loss as a complication of chronic inflammatory diseases
- Recent advances on identifying the underlying mechanisms
- Clinical perspectives, with the most promising pharmacological drug classes
Discover Dr Schue’s presentation down below
CILcare sponsored the 2022 edition of the Inner Ear Disorders Therapeutics Summit. Learn more about the event here.
